PATHWAYS pilot projects
PATHWAYS health pilot projects will impact 20,000+ Indigenous Peoples in Canada.
Four Indigenous communities – representing approximately 20,000 members burdened with diabetes – have been selected for health pilot project funding through PATHWAYS - Indigenous Health Collaborations. These community-driven projects are intended to empower members living with chronic diseases and improve health outcomes. Further investments in other chronic illnesses, such as interstitial lung disease, are planned following the successful launch of these four initial pilot projects in 2021. Boehringer Ingelheim (Canada) Ltd. also recently announced a significant diabetes investment with Research Manitoba.
